Alerts will be sent to your verified email
Verify EmailVISTAPH
Vista Pharma
|
Vivo Bio Tech
|
Shanmuga Hospital
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-9.45 % | 8.25 % | 55.38 % |
5yr average Equity Multiplier
|
1.52 | 2.25 | 1.81 |
5yr Average Asset Turnover Ratio
|
0.14 | 0.54 | 2.29 |
5yr Avg Net Profit Margin
|
-199.64 % | 6.78 % | 13.52 % |
Price to Book
|
1.45 | 0.85 | 0.0 |
P/E
|
0.0 | 9.12 | 14.88 |
5yr Avg Cash Conversion Cycle
|
397.29 Days | 69.38 Days | -0.97 Days |
Inventory Days
|
3019.63 Days | 71.5 Days | 11.41 Days |
Days Receivable
|
452.93 Days | 97.07 Days | 54.37 Days |
Days Payable
|
1804.78 Days | 108.42 Days | 38.41 Days |
5yr Average Interest Coverage Ratio
|
-2.3 | 2.17 | 103.51 |
5yr Avg ROCE
|
-7.56 % | 14.55 % | 68.42 % |
5yr Avg Operating Profit Margin
|
-188.68 % | 35.36 % | 20.12 % |
5 yr average Debt to Equity
|
0.33 | 1.09 | 0.39 |
5yr CAGR Net Profit
|
4.15 % | -10.64 % | -4.78 % |
5yr Average Return on Assets
|
-6.28 % | 4.02 % | 33.09 % |
Shareholdings
|
|||
Promoter Holding
|
21.19 % | 39.06 % | 72.11 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-14.25 % | -3.1 % | 0.16 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
Vista Pharma
|
Vivo Bio Tech
|
Shanmuga Hospital
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|